Atlas Trials

Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

Clinical trial NCT02206503 · COMPLETED

Trial details

NCT number
NCT02206503
Sponsor
Fondazione EMN Italy Onlus
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-03-01
Primary completion
2015-04-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.